Oral Solid Dosage Pharmaceutical Formulation Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Oral Solid Dosage Pharmaceutical Formulation Market by Dosage Form (Tablets, Capsules, Powders and Granules, Lozenges and Pastilles, and Gummies), by Drug Release Mechanism (Immediate Release, Delayed Release, Sustained Release, Controlled Release, and Extended Release), by Formulation Technology (Conventional Oral Solid Formulations, Modified-Release Technologies, Taste-Masking Technologies, Fixed-Dose Combinations (FDCs), and Orally Disintegrating Tablets (ODTs)), Therapeutic Area, End-user, and Regional Analysis from 2026 to 2033

ID: PMRREP36149| 188 Pages | 16 Feb 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Oral Solid Dosage Pharmaceutical Formulation Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Recent Product Launches
    3. Regulatory Landscape
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Price Trend Analysis, 2020 - 2033
    1. Key Highlights
    2. Key Factors Impacting Product Prices
    3. Pricing Analysis, By Product Type
    4. Regional Prices and Product Preferences
  5. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    3. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis and Volume (Units) Analysis, By Product, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
        1. Tablets
        2. Conventional/Immediate Release
        3. Modified Release
        4. Chewable Tablets
        5. Effervescent Tablets
        6. Capsules
        7. Hard Gelatin Capsules
        8. Soft Gelatin Capsules
        9. Others
        10. Powders and Granules
        11. Lozenges and Pastilles
        12. Gummies
      4. Market Attractiveness Analysis: By Product
    4. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Drug Release Mechanism
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Release Mechanism, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
        1. Immediate Release
        2. Delayed Release
        3. Sustained Release
        4. Controlled Release
        5. Extended Release
      4. Market Attractiveness Analysis: By Drug Release Mechanism
    5. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Formulation Technology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Formulation Technology, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
        1. Conventional Oral Solid Formulations
        2. Modified-Release Technologies
        3. Taste-Masking Technologies
        4. Fixed-Dose Combinations (FDCs)
        5. Orally Disintegrating Tablets (ODTS)
      4. Market Attractiveness Analysis: By Formulation Technology
    6. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Therapeutic Area
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapeutic Area, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
        1. Cardiovascular
        2. Central Nervous System (CNS)
        3. Anti-infectives
        4. Gastrointestinal
        5. Pain Management & Anti-inflammatory
        6. Respiratory
        7. Oncology
        8. Others
        9. Market Attractiveness Analysis: By Therapeutic Area
    7. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
        1. Pharmaceutical Companies
        2. Generic Pharmaceutical Companies
        3. Contract Development & Manufacturing Organizations (CDMOs)
        4. Others
      4. Market Attractiveness Analysis: End User
  6. Global Oral Solid Dosage Pharmaceutical Formulation Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
        1. Tablets
        2. Conventional/Immediate Release
        3. Modified Release
        4. Chewable Tablets
        5. Effervescent Tablets
        6. Capsules
        7. Hard Gelatin Capsules
        8. Soft Gelatin Capsules
        9. Others
        10. Powders and Granules
        11. Lozenges and Pastilles
        12. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  8. Europe Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
        1. Tablets
        2. Conventional/Immediate Release
        3. Modified Release
        4. Chewable Tablets
        5. Effervescent Tablets
        6. Capsules
        7. Hard Gelatin Capsules
        8. Soft Gelatin Capsules
        9. Others
        10. Powders and Granules
        11. Lozenges and Pastilles
        12. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  9. East Asia Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
        1. Tablets
        2. Conventional/Immediate Release
        3. Modified Release
        4. Chewable Tablets
        5. Effervescent Tablets
        6. Capsules
        7. Hard Gelatin Capsules
        8. Soft Gelatin Capsules
        9. Others
        10. Powders and Granules
        11. Lozenges and Pastilles
        12. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  10. South Asia & Oceania Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Tablets
        1. Conventional/Immediate Release
        2. Modified Release
        3. Chewable Tablets
        4. Effervescent Tablets
      2. Capsules
        1. Hard Gelatin Capsules
        2. Soft Gelatin Capsules
        3. Others
      3. Powders and Granules
      4. Lozenges and Pastilles
      5. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  11. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Tablets
        1. Conventional/Immediate Release
        2. Modified Release
        3. Chewable Tablets
        4. Effervescent Tablets
      2. Capsules
        1. Hard Gelatin Capsules
        2. Soft Gelatin Capsules
        3. Others
      3. Powders and Granules
      4. Lozenges and Pastilles
      5. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  12. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product
      3. By Drug Release Mechanism
      4. By Formulation Technology
      5. By Therapeutic Area
      6. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product, 2026 - 2033
      1. Tablets
        1. Conventional/Immediate Release
        2. Modified Release
        3. Chewable Tablets
        4. Effervescent Tablets
      2. Capsules
        1. Hard Gelatin Capsules
        2. Soft Gelatin Capsules
        3. Others
      3. Powders and Granules
      4. Lozenges and Pastilles
      5. Gummies
    5. Market Size (US$ Bn) Analysis and Forecast, By Drug Release Mechanism, 2026 - 2033
      1. Immediate Release
      2. Delayed Release
      3. Sustained Release
      4. Controlled Release Extended Release
    6. Market Size (US$ Bn) Analysis and Forecast, By Formulation Technology, 2026 - 2033
      1. Conventional Oral Solid Formulations
      2. Modified-Release Technologies
      3. Taste-Masking Technologies
      4. Fixed-Dose Combinations (FDCs)
      5. Orally Disintegrating Tablets (ODTS)
    7. Market Size (US$ Bn) Analysis and Forecast, By Therapeutic Area, 2026 - 2033
      1. Cardiovascular
      2. Central Nervous System (CNS)
      3. Anti-infectives
      4. Gastrointestinal
      5. Pain Management & Anti-inflammatory
      6. Respiratory
      7. Oncology
      8. Others
    8. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical Companies
      2. Generic Pharmaceutical Companies
      3. Contract Development & Manufacturing Organizations (CDMOs)
      4. Others
    9. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details - Overview, Recent Developments)
      1. AstraZeneca Plc.
        1. Overview
        2. Segments and Product & End User
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Bristol-Myers Squibb Company
      3. Eli Lilly and Company
      4. Gilead Sciences
      5. Merck and Co. Inc.
      6. Novartis AG
      7. Pfizer Inc.
      8. AbbVie Inc.
      9. Boehringer Ingelheim GmbH
      10. F. Hoffman-La-Roche Ltd.
      11. Johnson and Johnson
      12. Biogen Inc.
      13. Bayer AG
      14. Teva Pharmaceuticals
      15. Amgen Inc.
      16. Others
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate